Soares do Brito Joaquim, Lopes-Brás Raquel, Abrunhosa-Branquinho André, Fernandes Isabel, Gomes Inês, Casimiro Sandra, Costa Luís
Department of Orthopedics, Centro Hospitalar Universitário Lisboa Norte, 1649-028 Lisbon, Portugal.
Department of Medical Oncology, Centro Hospitalar Universitário Lisboa Norte, 1649-028 Lisbon, Portugal.
Cancers (Basel). 2022 Feb 11;14(4):893. doi: 10.3390/cancers14040893.
Advances in medical and surgical treatment have played a major role in increasing the survival rates of cancer patients with metastatic bone disease. The clinical course of patients with bone metastases is often impaired by bone complications, such as bone fractures, which have a substantial negative impact on clinical outcomes. To optimize clinical results and prevent a detrimental impact on patients' health, a tailored approach should be defined for any given patient. The optimal management of impending or pathologic fractures is unknown and relies on a multidisciplinary approach to tailor clinical decisions to each individual patient. The ability to control systemic disease, the extent, location and nature of bone metastases, and the biology of the underlying tumor, are the main factors that will define the strategy to follow. The present review covers the most recent data regarding impending and pathologic fractures in patients with bone metastases, and discusses the medical and surgical management of patients presenting with metastatic bone disease in different clinical settings.
医学和外科治疗的进展在提高转移性骨病癌症患者的生存率方面发挥了重要作用。骨转移患者的临床病程常因骨并发症(如骨折)而受到影响,这些并发症对临床结局有重大负面影响。为了优化临床结果并防止对患者健康产生不利影响,应为任何特定患者制定量身定制的方法。对于即将发生的或病理性骨折的最佳管理尚不清楚,并且依赖多学科方法来根据每个患者的情况定制临床决策。控制全身疾病的能力、骨转移的范围、位置和性质以及潜在肿瘤的生物学特性,是决定后续治疗策略的主要因素。本综述涵盖了有关骨转移患者即将发生的和病理性骨折的最新数据,并讨论了在不同临床情况下出现转移性骨病患者的内科和外科治疗。